The effects of monoamine oxidase inhibitors on spinal synaptic activity.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004558:Electric Stimulation; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology; D007796:Laminectomy; D008784:Methysergide / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000032:analysis; D010293:Pargyline / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D012018:Reflex / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000032:analysis / Q000378:metabolism; D013116:Spinal Cord / Q000032:analysis; D013127:Spinal Nerves; D013569:Synapses / Q000187:drug effects*; D014191:Tranylcypromine / Q000494:pharmacology; D014363:Tryptamines / Q000494:pharmacology; D014364:Tryptophan / Q000494:pharmacology
D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; D011725:Pyridines; D014363:Tryptamines; D010643:Phenoxybenzamine; D012701:Serotonin; D014191:Tranylcypromine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D014364:Tryptophan; D010293:Pargyline; D006916:5-Hydroxytryptophan; D009526:Nialamide; D009638:Norepinephrine; D008784:Methysergide